SCHEMBL19986699

SCHEMBL19986699

Cc1cncc(C)c1NCCNC(=O)Nc1cccc(F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
TAAR1 Q96RJ0 1/20 0.51
RAB9A P51151 7/20 0.49
NPC1 O15118 6/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 5/20 0.48
GBA1 P04062 1/20 0.48
MARS1 P56192 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
NAMPT P43490 1/20 0.46
MEN1 O00255 3/20 0.46
EPHX2 P34913 1/20 0.46
BRD4 O60885 1/20 0.46
MTOR P42345 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986631 0.88 KMT2A (0.53) LMNARAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL19986700 0.86 LMNA (0.53) LMNATAAR1RAB9ANPC1L3MBTL1
SCHEMBL19986564 0.84 NAMPT (0.52) LMNARAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL19986554 0.84 MEN1 (0.47) LMNAKMT2ASMN1; SMN2NAMPTMEN1
SCHEMBL19986446 0.84 KMT2A (0.49) LMNARAB9ANPC1KMT2ATP53
SCHEMBL19986507 0.81 KMT2A (0.38) KMT2ATP53NAMPTMEN1EPHX2
SCHEMBL19986701 0.79 MARS1 (0.59) LMNATAAR1RAB9ANPC1L3MBTL1
SCHEMBL19986708 0.78 KDM4E (0.39) KMT2AMARS1NAMPTMEN1EPHX2
SCHEMBL5054174 0.74 MARS1 (0.61) LMNATAAR1RAB9ANPC1KMT2A
SCHEMBL19986718 0.74 ALDH1A1 (0.42) RAB9ANPC1KMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018050110-A1 NOVEL CAPSID PROTEIN ASSEMBLY INHIBITOR 正大天晴药业集团股份有限公司 2018-03-22 WO disclosed